| Product Code: ETC6680539 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of insulin biosimilars to Cape Verde in 2024 saw Portugal, Italy, Senegal, Areas, nes, and Belgium emerge as the top exporting countries. Despite high concentration levels indicated by the HHI, the market experienced a significant growth with a CAGR of 16.93% from 2020 to 2024. However, there was a notable decline in growth rate from 2023 to 2024, indicating a challenging year for the industry. Overall, the dynamics of the insulin biosimilars market in Cape Verde reflect a mix of opportunities and challenges for stakeholders in the sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cape Verde Insulin Biosimilars Market Overview |
3.1 Cape Verde Country Macro Economic Indicators |
3.2 Cape Verde Insulin Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Cape Verde Insulin Biosimilars Market - Industry Life Cycle |
3.4 Cape Verde Insulin Biosimilars Market - Porter's Five Forces |
3.5 Cape Verde Insulin Biosimilars Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Cape Verde Insulin Biosimilars Market Revenues & Volume Share, By Indicative, 2021 & 2031F |
3.7 Cape Verde Insulin Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Cape Verde Insulin Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cape Verde Insulin Biosimilars Market Trends |
6 Cape Verde Insulin Biosimilars Market, By Types |
6.1 Cape Verde Insulin Biosimilars Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Rapid-acting biosimilar, 2021- 2031F |
6.1.4 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Long-acting biosimilar, 2021- 2031F |
6.1.5 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Premixed biosimilar, 2021- 2031F |
6.2 Cape Verde Insulin Biosimilars Market, By Indicative |
6.2.1 Overview and Analysis |
6.2.2 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.2.3 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.3 Cape Verde Insulin Biosimilars Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Cape Verde Insulin Biosimilars Market Revenues & Volume, By Others, 2021- 2031F |
7 Cape Verde Insulin Biosimilars Market Import-Export Trade Statistics |
7.1 Cape Verde Insulin Biosimilars Market Export to Major Countries |
7.2 Cape Verde Insulin Biosimilars Market Imports from Major Countries |
8 Cape Verde Insulin Biosimilars Market Key Performance Indicators |
9 Cape Verde Insulin Biosimilars Market - Opportunity Assessment |
9.1 Cape Verde Insulin Biosimilars Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Cape Verde Insulin Biosimilars Market Opportunity Assessment, By Indicative, 2021 & 2031F |
9.3 Cape Verde Insulin Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Cape Verde Insulin Biosimilars Market - Competitive Landscape |
10.1 Cape Verde Insulin Biosimilars Market Revenue Share, By Companies, 2024 |
10.2 Cape Verde Insulin Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |